At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
MAKO 7device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cytological Evaluation of Specimens Collected With the MAKO 7 Device in Pre Salpingo-Oophorectomy Subjects for Determination and/or Differentiation of Normal Versus Atypical Versus Malignant Cells
In Brief
An observational study evaluating MAKO 7 for BRCA1 Mutation and 2 related conditions. Completed, enrolled 50 participants across 3 sites.
Detailed Summary
This study evaluates the ability of the MAKO 7 device to collect various cells
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartNov 2016
First PostedNov 2016
Primary CompletionSep 2017
TodayJul 2026
First PostedNov 29, 2016
Enrollment StartNov 2, 2016
Primary CompletionSep 27, 2017
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 9.6 years ago
Interventions
MAKO 7device
Hysteroscopic cell sampling